Literature DB >> 16735287

Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution.

C Aceijas1, S R Friedman, H L F Cooper, L Wiessing, G V Stimson, M Hickman.   

Abstract

OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution.
METHODS: Literature review of both grey and published literature including updates from previously reported estimates on estimates of IDU population and data sources giving age and gender breakdowns. The scope area was developing/transitional countries and the reference period was 1998-2005.
RESULTS: Estimates of IDU numbers were available in 105 countries and 243 subnational areas. The largest IDU populations were reported from Brazil, China, India, and Russia (0.8 m, 1.9 m, 1.1 m, and 1.6 m respectively). Subnational areas with the largest IDU populations (35,000-79,000) are: Warsaw (Poland); Barnadul, Irtkustk, Nizhny-Novgorod, Penza, Voronez, St Petersburg, and Volgograd (Russia); New Delhi and Mumbai (India); Jakarta (Indonesia), and Bangkok (Thailand). By region, Eastern Europe and Central Asia have the largest IDU prevalence (median 0.65%) (min 0.3%; max 2.2%; Q1 0.39%; Q3 1.32%) [corrected] followed by Asia and Pacific: 0.24% (min 0.004%; max 1.47%; Q1 0.14%; Q3 1.47%) [corrected] In the Middle East and Africa the median value equals 0.2% (min 0.0003%; max 0.35%; Q1 0.11%; Q3 0.23%) [corrected] and in Latin America and the Caribbean: 0.12% (min 0.11%; max 0.69%; Q1 0.04%; Q3 0.13%) [corrected] Subnational areas with the highest IDU prevalence among adults (8-14.9%) were Shymkent (Kazakhstan), Balti (Moldova), Astrakhan, Barnadul, Irtkustk, Khabarovsk, Kaliningrad, Naberezhnyje Chelny, Penza, Togliatti, Volgograd, Voronez, and Yaroslavl (Russia), Dushanbe (Tajikistan), Ashgabad (Turkmenistan), Ivano-Frankivsk and Pavlograd (Ukraine) and Imphal, Manipur (India). 66% (297/447) of the IDU estimates were reported without technical information. Data on the IDU age/gender distributions are also scarce or unavailable for many countries. In 11 Eastern European and Central Asian countries the age group <or=20-29 represented >50% of the total. The proportion of IDU men was 70%-90% in Eastern Europe and Central Asia, and there was a marked absence of data on women outside this region.
CONCLUSION: Unfortunately data on IDU prevalence available to national and international policymakers is of an unknown and probably yet to be tested quality. This study provide baseline figures but steps need to be taken now to improve the reporting and assessment of these critical data.

Entities:  

Mesh:

Year:  2006        PMID: 16735287      PMCID: PMC2576733          DOI: 10.1136/sti.2005.019471

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  12 in total

Review 1.  The emerging AIDS crisis in Russia: review of enabling factors and prevention needs.

Authors:  S C Kalichman; J A Kelly; K J Sikkema; A P Koslov; A Shaboltas; J Granskaya
Journal:  Int J STD AIDS       Date:  2000-02       Impact factor: 1.359

Review 2.  The global epidemiology of HIV/AIDS.

Authors:  L Morison
Journal:  Br Med Bull       Date:  2001       Impact factor: 4.291

Review 3.  The epidemics of injecting drug use and HIV in Asia.

Authors:  P D Ghys; W Bazant; M G Monteiro; S Calvani; S Lazzari
Journal:  AIDS       Date:  2001       Impact factor: 4.177

4.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

5.  The Warsaw Declaration: A framework for effective action on HIV/AIDS and injecting drug use. 2nd international policy dialogue on HIV/AIDS. Held in Warsaw, Poland, November 12-14, 2003.

Authors: 
Journal:  Can HIV AIDS Policy Law Rev       Date:  2003-12

6.  Global overview of injecting drug use and HIV infection.

Authors:  Clyde B McCoy; Frank Rodríguez
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

Review 7.  Racial/ethnic disparities in injection drug use in large US metropolitan areas.

Authors:  Hannah Cooper; Samuel R Friedman; Barbara Tempalski; Risa Friedman; Marie Keem
Journal:  Ann Epidemiol       Date:  2005-05       Impact factor: 3.797

8.  Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.

Authors:  Samuel R Friedman; Hannah Lf Cooper; Barbara Tempalski; Maria Keem; Risa Friedman; Peter L Flom; Don C Des Jarlais
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

9.  Global overview of injecting drug use and HIV infection among injecting drug users.

Authors:  Carmen Aceijas; Gerry V Stimson; Matthew Hickman; Tim Rhodes
Journal:  AIDS       Date:  2004-11-19       Impact factor: 4.177

10.  The rise of injecting drug use in East Africa: a case study from Kenya.

Authors:  Susan Beckerleg; Maggie Telfer; Gillian Lewando Hundt
Journal:  Harm Reduct J       Date:  2005-08-25
View more
  63 in total

1.  Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.

Authors:  Frederik Graw; Thomas Leitner; Ruy M Ribeiro
Journal:  Epidemics       Date:  2012-05-02       Impact factor: 4.396

2.  Improving analysis of the size and dynamics of AIDS epidemics.

Authors:  P D Ghys; N Walker; G P Garnett
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Thirty years on from Alma-Ata: Where have we come from? Where are we going?

Authors:  Trisha Greenhalgh
Journal:  Br J Gen Pract       Date:  2008-11       Impact factor: 5.386

4.  Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India.

Authors:  Shruti H Mehta; Darshan Sudarshi; Aylur K Srikrishnan; David D Celentano; Canjeevaram K Vasudevan; Santhanam Anand; Muniratnam Suresh Kumar; Carl Latkin; Suniti Solomon; Sunil S Solomon
Journal:  Addiction       Date:  2011-10-12       Impact factor: 6.526

5.  Getting to 90: linkage to HIV care among men who have sex with men and people who inject drugs in India.

Authors:  Allison M McFall; Shruti H Mehta; Aylur K Srikrishnan; Gregory M Lucas; Canjeevaram K Vasudevan; David D Celentano; Muniratnam S Kumar; Suniti Solomon; Sunil S Solomon
Journal:  AIDS Care       Date:  2016-04-07

Review 6.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

7.  Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.

Authors:  Allison M McFall; Sunil S Solomon; Greg M Lucas; David D Celentano; Aylur K Srikrishnan; Muniratnam S Kumar; Shruti H Mehta
Journal:  Addiction       Date:  2017-04-18       Impact factor: 6.526

8.  HIV among injection drug users and their intimate partners in Almaty, Kazakhstan.

Authors:  Nabila El-Bassel; Louisa Gilbert; Assel Terlikbayeva; Elwin Wu; Chris Beyrer; Stacey Shaw; Tim Hunt; Xin Ma; Mingway Chang; Leyla Ismayilova; Marat Tukeyev; Baurzhan Zhussupov; Yelena Rozental
Journal:  AIDS Behav       Date:  2013-09

9.  Overdose experiences among injection drug users in Bangkok, Thailand.

Authors:  M-J Milloy; Nadia Fairbairn; Kanna Hayashi; Paisan Suwannawong; Karyn Kaplan; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2010-05-13

10.  Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review.

Authors:  Savanna R Reid
Journal:  Harm Reduct J       Date:  2009-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.